arrow
J

Joan Gibert

cancer research program
H指数:12
被引数:365

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brief report: Artificial intelligence meets small cell lung cancer—integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC

简要报告: 人工智能与小细胞肺癌相遇-整合临床病理和整体影像数据以预测SCLC的预后

2026-04-200
OA
Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma

肿瘤突变负荷作为滤泡性淋巴瘤的预后生物标志物

Cancers
IF4.4
2026-02-260
OAAI
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study

液体活检-实体瘤治疗反应评价标准(LB-RECIST)在转移性结直肠癌(mCRC)患者中的临床验证:PLATFORM-B研究的结果

2025-09-030
OAAI
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer

一种基于放射组学的人工智能模型,用于评估局部结肠癌的复发风险

2025-07-160
OAAI
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives

结直肠癌腹膜癌病的液体活检:当前证据与未来展望

CANCERS
IF4.4
2025-04-260
OA
Nuclear Galectin-1 promotes KRAS- dependent activation of pancreatic cancer stellate cells

核半乳凝素-1促进KRAS依赖性胰腺癌星状细胞激活

2025-04-020
OA
The 66th ASH Annual Meeting Abstracts POSTER ABSTRACTS

第66届ASH年会摘要 海报摘要

BLOOD
IF23.1
2024-11-050
PRE
Genomic landscape of acquired resistance to first-line (1L) anti-EGFR treatment in metastatic colorectal cancer (mCRC) beyond the classical EGFR pathway: Findings from the PLATFORM-B study

对转移性结直肠癌(mCRC)中超越经典EGFR通路的一线(1L)抗EGFR治疗获得性耐药的基因组景观:PLATFORM-B研究的结果

2024-09-010
PRE
Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (1L) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study

循环肿瘤DNA (ctDNA) 检测RASWT转移性结直肠癌 (mCRC) 一线 (1L) 治疗的获得性耐药: 来自platform-b研究的见解

2024-06-010
PRE
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
2023-10-202
OAAI
A clinico-imaging predictive artificial intelligence model of relapse in colon cancer using baseline CT scans

使用基线ct扫描的结肠癌复发的临床成像预测人工智能模型

2023-10-010
OAAI
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy

免疫化疗一线治疗滤泡性淋巴瘤4项预后指标的评价

2023-04-256
OAAI
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia

多命中TET2突变作为寡单核细胞和明显的慢性粒细胞单核细胞白血病的差异分子特征

LEUKEMIA
IF13.4
2022-10-2210
PRE
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum

寡单核细胞CMML的结果和分子特征支持将其视为CMML连续体的第一阶段

2022-07-0615
OAAI